Journal of the American Chemical Society · 1999 · 69 citations · 37 references
PharmacyChemistryCarbohydrate ChemistryDrug DiscoveryStructural BiologyHeterocycle SynthesisMacromolecular AssemblyRetrosynthetic AnalysisAsymmetric Heterocycle SynthesisAsymmetric SynthesisFragment AssemblyNatural Product Total SynthesisPhosphonate InhibitorsProtein Tyrosine Phosphatase InhibitorsTotal Synthesis-derived Analogues
A convergent total synthesis leading to (+)-calyculin A and (−)-calyculin B ( 1 and 2 ), antipodes of the potent, highly selective and remarkably cell-permeable phosphatase inhibitors calyculins A and B, has been achieved. In the preceding paper we outlined the asymmetric synthesis of the C(9−25) spiroketal dipropionate subunit (+)- BC; herein we describe construction of the C(1−8) cyanotetraene, an asymmetric synthesis of the C(26−37) oxazole, fragment assembly and final elaboration to (+)- 1 and (−)- 2 . Highlights of the synthesis include: application of a one-pot three-component Suzuki reaction for the construction of phosphonate A, a bifunctional triene precursor of the light sensitive C(1−8) cyanotetraene subunit, an asymmetric synthesis of the C(26−32) oxazole (−)- D, exploiting the Silks−Odom 77 Se NMR protocol to assess enantiomeric purity, construction of the C(33−37) subtarget (−)- E in a highly stereocontrolled fashion via an acyliminium ion, and a concise, highly efficient sequence for fragment assembly and elaboration to (+)-calyculin A and (−)-calyculin B. The synthesis of (−)- 2 also confirms the structure of calyculin B, previously based only on spectral comparison with calyculin A.
37
David A. Evans, Michael D. Ennis, David J. Mathre · Journal of the American Chemical Society · 1982 · 1K citations